MedPath

SUN YAT-SEN MEMORIAL HOSPITAL,SUN YAT-SEN UNIVERSITY

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Adebrelimab, Camrelizumab Plus Apatinib as First-line Therapy in Patients With Advanced Hepatocellular Carcinoma

Phase 1
Recruiting
Conditions
Advanced Hepatocellular Carcinoma
Interventions
Drug: adebrelimab, camrelizumab plus apatinib
First Posted Date
2023-06-29
Last Posted Date
2024-02-21
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
52
Registration Number
NCT05924997
Locations
🇨🇳

Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China

Prospective Diagnostic Study on Perforator Localization of Anterolateral Thigh Flap With Perforator Locator

Not Applicable
Recruiting
Conditions
Blood Vessel Perforation
Interventions
Device: perforator locator
First Posted Date
2023-06-29
Last Posted Date
2024-05-16
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
82
Registration Number
NCT05924984
Locations
🇨🇳

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China

A Clinical Study of a Preoperative Translational Therapy for Unresectable Gallbladder Cancer

Phase 2
Not yet recruiting
Conditions
Unresectable Gallbladder Cancer
Interventions
Drug: Carrilizumab plus GEMOX
First Posted Date
2023-06-26
Last Posted Date
2023-06-26
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
37
Registration Number
NCT05919095
Locations
🇨🇳

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

Pemigatinib Combined With PD-1 Inhibitor in Unresectable or Metastatic Intrahepatic Cholangiocarcinoma

Phase 2
Recruiting
Conditions
Carcinoma
PD-1 Inhibitor
First-line Treatment
Intrahepatic Cholangiocarcinoma
Digestive System Neoplasms
Interventions
Drug: PD-1 Inhibitors
First Posted Date
2023-06-22
Last Posted Date
2023-06-22
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
30
Registration Number
NCT05913661
Locations
🇨🇳

Lei Zhang, Guangzhou, Guangdong, China

Correlation Between Pre-transplant ICI Exposure and Post-transplant Graft Rejection

Recruiting
Conditions
Graft Rejection
Immunotherapy
Hepatocellular Carcinoma
Immune Checkpoint Inhibitor
Interventions
Drug: Immune checkpoint inhibitor
First Posted Date
2023-06-22
Last Posted Date
2023-06-22
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
160
Registration Number
NCT05913583
Locations
🇨🇳

Organ Transplantation Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University,, Guangzhou, Guangdong, China

Effect of Preoperative Olfactory Training on Postoperative Delirium in the Elderly Undergoing Orthopedic Surgeries

Not Applicable
Not yet recruiting
Conditions
Postoperative Delirium
Preoperative Olfactory Training
Interventions
Behavioral: olfactory training
First Posted Date
2023-06-18
Last Posted Date
2023-06-18
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
450
Registration Number
NCT05908318

Aspirin Combined With Clopidogrel Versus Intravenous Alteplase for Acute Minor Stroke

Phase 4
Not yet recruiting
Conditions
Ischemic Stroke
Interventions
First Posted Date
2023-06-18
Last Posted Date
2023-06-18
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
472
Registration Number
NCT05910125
Locations
🇨🇳

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China

Preliminary Study on the Metastatic Rate and Clinical Significance of the Anterior Leaf of Vesicouterine Ligament in Early Stage Cervical Cancer

Recruiting
Conditions
Cervical Cancer
Interventions
Procedure: Type B resection or type C resection of the anterior leaf of vesicouterine ligament during the radical hysterectomy (type C)
First Posted Date
2023-06-15
Last Posted Date
2023-06-15
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
460
Registration Number
NCT05904977
Locations
🇨🇳

Huaiwu Lu, Guangzhou, Guangdong, China

Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial)

Phase 3
Recruiting
Conditions
HR Positive/HER2 Low Expression Metastatic Breast Cancer
Interventions
Other: Endocrine therapy
First Posted Date
2023-06-15
Last Posted Date
2023-06-22
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
288
Registration Number
NCT05904964
Locations
🇨🇳

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

🇨🇳

Hainan Qionghai People's Hospital, Qionghai, Hainan, China

🇨🇳

The Second Affiliated Hospital, Shantou University Medical College, Shantou, Guangdong, China

Optical Coherence Tomography Angiography Characteristics of Radiation Optic Neuropathy

Completed
Conditions
Optic Radiation Neuropathy Following Radiotherapy Procedure
Interventions
Radiation: head and neck radiation
First Posted Date
2023-06-09
Last Posted Date
2023-06-09
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Target Recruit Count
80
Registration Number
NCT05895851
Locations
🇨🇳

Zijing Li, Guangzhou, China

© Copyright 2025. All Rights Reserved by MedPath